Summary

GlobalData's new report, ¡°India In Vitro Diagnostics Market Outlook to 2016¡± provides key market data on the India In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories-clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

-Market size and company share data for In Vitro Diagnostics (IVD) market categories-clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
-Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
-2009 company shares and distribution shares data for each of the seven market categories.
-Global corporate-level profiles of key companies operating within the India In Vitro Diagnostics (IVD) market.
-Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

-Develop business strategies by identifying the key market categories and segments poised for strong growth.
-Develop market-entry and market expansion strategies.
-Design competition strategies by identifying who-stands-where in the India In Vitro Diagnostics (IVD) competitive landscape.
-Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
-What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

Table of Contents

 

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 In Vitro Diagnostics In India 16
3.1 In Vitro Diagnostics, Market Segmentation 16
3.2 In Vitro Diagnostics, India, Overall Revenue ($m), 2002-2016 17
3.3 In Vitro Diagnostics Market, India, Revenue Mix ($m), 2009 19
3.4 In Vitro Diagnostics Market, India, Category Contribution (%), 2009 20
3.5 In Vitro Diagnostics, India, Company Share (2008-2009) 26
4 Clinical Chemistry In India 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, India, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, India, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, India, Company Share (2008-2009) 44
5 Genetic Testing In India 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, India, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, India, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, India, Company Share (2008-2009) 54
6 Haematology In India 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, India, Revenue Mix ($m), 2009 56
6.3 Haematology Market, India, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 69
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 73
6.4.5 Haematology Cell Counters Revenue (2002-2016) 76
6.5 Haematology Distribution Share (2008-2009) 80
6.6 Haematology, India, Company Share (2008-2009) 81
7 Histology And Cytology In India 83
7.1 Histology and Cytology, Market Segmentation 83
7.2 Histology and Cytology Market, India, Revenue Mix ($m), 2009 84
7.3 Histology And Cytology Market, India, Category Contribution (%), 2009 85
7.4 Histology And Cytology Overall Revenue (2002-2016) 86
7.4.1 Histology Revenue (2002-2016) 90
7.5 Histology And Cytology Distribution Share (2008-2009) 94
7.6 Histology And Cytology, India, Company Share (2008-2009) 95
8 Immuno Chemistry In India 96
8.1 Immuno Chemistry, Market Segmentation 96
8.2 Immuno Chemistry Market, India, Revenue Mix ($m), 2009 97
8.3 Immuno Chemistry Market, India, Category Contribution (%), 2009 98
8.4 Immuno Chemistry Overall Revenue (2002-2016) 99
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 103
8.4.2 Drug Related Testing Revenue (2002-2016) 107
8.4.3 Endocrinology Tests Revenue (2002-2016) 109
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 113
8.5 Immuno Chemistry Distribution Share (2008-2009) 116
8.6 Immuno Chemistry, India, Company Share (2008-2009) 117
9 Infectious Immunology In India 119
9.1 Infectious Immunology, Market Segmentation 119
9.2 Infectious Immunology Market, India, Revenue Mix ($m), 2009 120
9.3 Infectious Immunology Market, India, Category Contribution (%), 2009 121
9.4 Infectious Immunology Overall Revenue (2002-2016) 122
9.5 Infectious Immunology Distribution Share (2008-2009) 126
9.6 Infectious Immunology, India, Company Share (2008-2009) 127
10 Microbiology Culture In India 129
10.1 Microbiology Culture, Market Segmentation 129
10.2 Microbiology Culture Market, India, Revenue Mix ($m), 2009 130
10.3 Microbiology Culture Market, India, Category Contribution (%), 2009 131
10.4 Microbiology Culture Overall Revenue (2002-2016) 132
10.4.1 Microbiology Analyzers Revenue (2002-2016) 136
10.5 Microbiology Culture Distribution Share (2008-2009) 140
10.6 Microbiology Culture, India, Company Share (2008-2009) 141
11 Overview of Key Companies in India In Vitro Diagnostics Market 143
11.1 F. Hoffmann-La Roche Ltd. 143
11.1.1 Company Overview 143
11.1.2 Share in the India In Vitro Diagnostics Market 143
11.2 Beckman Coulter, Inc. 144
11.2.1 Company Overview 144
11.2.2 Share in the India In Vitro Diagnostics Market 144
11.3 Transasia Bio-Medicals Ltd. 145
11.3.1 Company Overview 145
11.3.2 Share in the India In Vitro Diagnostics Market 145
11.4 Siemens Healthcare 146
11.4.1 Company Overview 146
11.4.2 Share in the India In Vitro Diagnostics Market 146
11.5 Abbott Laboratories 147
11.5.1 Company Overview 147
11.5.2 Share in the India In Vitro Diagnostics Market 147
11.6 Sysmex Corporation 148
11.6.1 Company Overview 148
11.6.2 Share in the India In Vitro Diagnostics Market 148
11.7 Dade Behring Holdings, Inc. (Inactive) 149
11.7.1 Company Overview 149
11.8 Inverness Medical Innovations, Inc. 149
11.8.1 Company Overview 149
11.9 Becton, Dickinson and Company 149
11.9.1 Company Overview 149
11.10 bioMerieux S.A. 150
11.10.1 Company Overview 150
11.11 Bio-Rad Laboratories, Inc. 150
11.11.1 Company Overview 150
11.12 Hologic, Inc. 151
11.12.1 Company Overview 151
11.13 OLYMPUS CORPORATION 151
11.13.1 Company Overview 151
11.14 Ortho-Clinical Diagnostics Inc. 152
11.14.1 Company Overview 152
11.15 DiaSorin S.p.A 152
11.15.1 Company Overview 152
11.16 Qiagen N.V. 152
11.16.1 Company Overview 152
11.17 Gen-Probe Incorporated 153
11.17.1 Company Overview 153
11.18 Phadia AB 153
11.18.1 Company Overview 153
11.19 Tulip Group 154
11.19.1 Company Overview 154
11.20 Trivitron Group of Companies 154
11.20.1 Company Overview 154
11.21 Span Diagnostics Ltd. 154
11.21.1 Company Overview 154
11.22 Accurex Biomedical Pvt. Ltd. 155
11.22.1 Company Overview 155
11.23 Bhat Bio-tech India (P)Ltd 155
11.23.1 Company Overview 155
11.24 Invitro Biotech Ltd. 155
11.24.1 Company Overview 155
11.25 ATNT Laboratories 155
11.25.1 Company Overview 155
11.26 Jindal Medical & Scientific Instruments Company (Pvt.) Ltd. 156
11.26.1 Company Overview 156
11.27 Professional Biotech Pvt. Ltd. 156
11.27.1 Company Overview 156
11.28 Spectral Diagnostic Pvt. Ltd. 156
11.28.1 Company Overview 156
11.29 Embee Diagnostics 156
11.29.1 Company Overview 156
11.30 CL Micromed Pvt. Ltd. 157
11.30.1 Company Overview 157
11.31 J.Mitra & Co. Ltd. 157
11.31.1 Company Overview 157
11.32 Ark Diagnostics Pvt. Ltd. 157
11.32.1 Company Overview 157
11.33 Agappe Diagnostics Ltd. 158
11.33.1 Company Overview 158
11.34 Accura Diagnostics Inc 158
11.34.1 Company Overview 158
12 In Vitro Diagnostics Market Pipeline Products 159
12.1 Clinical Chemisty Market Pipeline Products 159
12.2 Immuno Chemistry Market Pipeline Products 161
12.3 Haematology Market Pipeline Products 162
12.4 Infectious Immunology Market Pipeline Products 163
12.5 Microbiology Culture Market Pipeline Products 165
12.6 Histology and Cytology Market Pipeline Products 166
12.7 Genetic Testing Market Pipeline Products 167
13 Financial Deals Landscape 169
13.1 Acquisition 169
13.1.1 PerkinElmer Acquires Surendra Genetic Labs 169
13.2 Partnerships 170
13.2.1 QIAGEN Enters Into Distribution Agreement With Celera 170
13.2.2 Sequenom Enters Into Licensing Agreement With Optherion 171
13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 172
13.2.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 173
13.2.5 DxS Signs Cross-Licensing Agreement With  Epigenomics 174
14 Recent Developments 175
14.1 Strategy And Business Planning 175
14.1.1 Feb 17, 2010: PerkinElmer Launches New Health Screening Lab In India 175
14.1.2 Dec 15, 2009: Covance Opens New Clinical Development Offices In South Korea And India, Expands Offices In Japan And Hong Kong 175
14.1.3 Oct 18, 2009: QBC Opens Engineering Services Center In India 176
14.2 Product News 176
14.2.1 Jan 28, 2010: Biomagnetics Diagnostics Initiates Clinical Trial For Integrated Optical Biosensor To Detect Malaria And Tuberculosis 176
14.2.2 Apr 01, 2009: Landmark Study Shows Significant Reduction In Death Rate From Cervical Cancer With The Digene HPV Test Compared To Other Methods Including Pap 177
14.2.3 Feb 24, 2009: Zila Launches ViziLite Plus In India 178
14.2.4 Nov 10, 2008: Diagenic Announces Launch Of First Breast Cancer Gene-Expression Blood Test 178
14.2.5 Nov 08, 2008: World Premiere Of A Revolutionary Breast Cancer Test 179
15 Appendix 180
15.1 Definitions of Markets Covered in the Report 181
15.1.1 In Vitro Diagnostics 181
15.2 Research Methodology 189
15.3 Secondary Research 190
15.4 Primary Research 190
15.5 Models 191
15.6 Forecasts 191
15.7 Expert Panels 191
15.8 GlobalData Consulting 191
15.9 Currency Conversion 192
15.10 Contact Us 192
15.11 Disclaimer 192

 

1.1 List of Tables
Table 1: In Vitro Diagnostics, India, Overall Revenue ($m), 2002-2016 18
Table 2: In Vitro Diagnostics Market, India, Category Contribution (%), 2009 20
Table 3: In Vitro Diagnostics, India, Cross-Category Analysis, 2002-2016 21
Table 4: In Vitro Diagnostics, India, Overall Revenue ($m), Historic, 2002-2009 23
Table 5: In Vitro Diagnostics, India, Overall Revenue ($m), Forecast, 2009-2016 25
Table 6: In Vitro Diagnostics, India, Company Share by Revenue ($m), 2008-2009 27
Table 7: Clinical Chemistry Market, India, Category Contribution (%), 2009 30
Table 8: Clinical Chemistry, India, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 9: Clinical Chemistry, India, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 10: Clinical Chemisty Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36
Table 11: Clinical Chemisty Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38
Table 12: Urine Analysis, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 13: Urine Analysis, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Table 14: Clinical Chemistry, India, Distribution Share by Revenue ($m), 2008-2009 43
Table 15: Clinical Chemistry, India, Company Share by Revenue ($m), 2008-2009 45
Table 16: Genetic Testing Market, India, Category Contribution (%), 2009 48
Table 17: Genetic Testing, India, Revenue ($m) by Segment, Historic, 2002-2009 50
Table 18: Genetic Testing, India, Revenue ($m) by Segment, Forecast, 2009-2016 52
Table 19: Genetic Testing, India, Distribution Share by Revenue ($m), 2008-2009 53
Table 20: Genetic Testing, India, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, India, Category Contribution (%), 2009 57
Table 22: Haematology, India, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, India, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65
Table 26: Immunohaematology, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Table 27: Immunohaematology, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Table 28: Haemostasis, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Table 29: Haemostasis, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Table 30: Haematology Rapid Tests, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 73
Table 31: Haematology Rapid Tests, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 75
Table 32: Haematology Cell Counters, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 77
Table 33: Haematology Cell Counters, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 79
Table 34: Haematology, India, Distribution Share by Revenue ($m), 2008-2009 80
Table 35: Haematology, India, Company Share by Revenue ($m), 2008-2009 82
Table 36: Histology And Cytology Market, India, Category Contribution (%), 2009 85
Table 37: Histology And Cytology, India, Revenue ($m) by Segment, Historic, 2002-2009 87
Table 38: Histology And Cytology, India, Revenue ($m) by Segment, Forecast, 2009-2016 89
Table 39: Histology, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 91
Table 40: Histology, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 93
Table 41: Histology And Cytology, India, Distribution Share by Revenue ($m), 2008-2009 94
Table 42: Histology And Cytology, India, Company Share by Revenue ($m), 2008-2009 95
Table 43: Immuno Chemistry Market, India, Category Contribution (%), 2009 98
Table 44: Immuno Chemistry, India, Revenue ($m) by Segment, Historic, 2002-2009 100
Table 45: Immuno Chemistry, India, Revenue ($m) by Segment, Forecast, 2009-2016 102
Table 46: Disease Specific Immunochemistry, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 104
Table 47: Disease Specific Immunochemistry, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 106
Table 48: Drug Related Testing, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Table 49: Drug Related Testing, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Table 50: Endocrinology Tests, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 110
Table 51: Endocrinology Tests, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 112
Table 52: Immunochemistry Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113
Table 53: Immunochemistry Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 115
Table 54: Immuno Chemistry, India, Distribution Share by Revenue ($m), 2008-2009 116
Table 55: Immuno Chemistry, India, Company Share by Revenue ($m), 2008-2009 118
Table 56: Infectious Immunology Market, India, Category Contribution (%), 2009 121
Table 57: Infectious Immunology, India, Revenue ($m) by Segment, Historic, 2002-2009 123
Table 58: Infectious Immunology, India, Revenue ($m) by Segment, Forecast, 2009-2016 125
Table 59: Infectious Immunology, India, Distribution Share by Revenue ($m), 2008-2009 126
Table 60: Infectious Immunology, India, Company Share by Revenue ($m), 2008-2009 128
Table 61: Microbiology Culture Market, India, Category Contribution (%), 2009 131
Table 62: Microbiology Culture, India, Revenue ($m) by Segment, Historic, 2002-2009 133
Table 63: Microbiology Culture, India, Revenue ($m) by Segment, Forecast, 2009-2016 135
Table 64: Microbiology Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 137
Table 65: Microbiology Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 139
Table 66: Microbiology Culture, India, Distribution Share by Revenue ($m), 2008-2009 140
Table 67: Microbiology Culture, India, Company Share by Revenue ($m), 2008-2009 142
Table 68: Clinical Chemisty Market Pipeline Products 159
Table 69: Immuno Chemistry Market Pipeline Products 161
Table 70: Haematology Market Pipeline Products 162
Table 71: Infectious Immunology Market Pipeline Products 163
Table 72: Microbiology Culture Market Pipeline Products 165
Table 73: Histology and Cytology Market Pipeline Products 166
Table 74: Genetic Testing Market Pipeline Products 167
Table 75: PerkinElmer Acquires Surendra Genetic Labs 169
Table 76: QIAGEN Enters Into Distribution Agreement With Celera 170
Table 77: Sequenom Enters Into Licensing Agreement With Optherion 171
Table 78: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 172
Table 79: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 173
Table 80: DxS Signs Cross-Licensing Agreement With  Epigenomics 174
Table 81: USD to Local Currency, India, Average Actual Rate 2002-2009 192

 

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 16
Figure 2: In Vitro Diagnostics, India, Overall Revenue ($m), 2002-2016 17
Figure 3: In Vitro Diagnostics Market, India, Revenue Mix ($m), 2009 19
Figure 4: In Vitro Diagnostics Market, India, Category Contribution (%), 2009 20
Figure 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2002-2016 21
Figure 6: In Vitro Diagnostics, India, Overall Revenue ($m), Historic, 2002-2009 22
Figure 7: In Vitro Diagnostics, India, Overall Revenue ($m), Forecast, 2009-2016 24
Figure 8: In Vitro Diagnostics, India, Company Share (%), 2009 26
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, India, Revenue Mix ($m), 2009 29
Figure 11: Clinical Chemistry Market, India, Category Contribution (%), 2009 30
Figure 12: Clinical Chemistry, India, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 13: Clinical Chemistry, India, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 14: Clinical Chemisty Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Figure 15: Clinical Chemisty Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Figure 16: Urine Analysis, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 17: Urine Analysis, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 18: Clinical Chemistry, India, Company Share (%), 2009 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, India, Revenue Mix ($m), 2009 47
Figure 21: Genetic Testing Market, India, Category Contribution (%), 2009 48
Figure 22: Genetic Testing, India, Revenue ($m) by Segment, Historic, 2002-2009 49
Figure 23: Genetic Testing, India, Revenue ($m) by Segment, Forecast, 2009-2016 51
Figure 24: Genetic Testing, India, Company Share (%), 2009 54
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, India, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, India, Category Contribution (%), 2009 57
Figure 28: Haematology, India, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, India, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Figure 33: Immunohaematology, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 67
Figure 34: Haemostasis, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 69
Figure 35: Haemostasis, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 71
Figure 36: Haematology Rapid Tests, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 73
Figure 37: Haematology Rapid Tests, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 74
Figure 38: Haematology Cell Counters, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 76
Figure 39: Haematology Cell Counters, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 78
Figure 40: Haematology, India, Company Share (%), 2009 81
Figure 41: Histology And Cytology, Market Segmentation 83
Figure 42: Histology And Cytology Market, India, Revenue Mix ($m), 2009 84
Figure 43: Histology And Cytology Market, India, Category Contribution (%), 2009 85
Figure 44: Histology And Cytology, India, Revenue ($m) by Segment, Historic, 2002-2009 86
Figure 45: Histology And Cytology, India, Revenue ($m) by Segment, Forecast, 2009-2016 88
Figure 46: Histology, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 90
Figure 47: Histology, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 92
Figure 48: Histology And Cytology, India, Company Share (%), 2009 95
Figure 49: Immuno Chemistry, Market Segmentation 96
Figure 50: Immuno Chemistry Market, India, Revenue Mix ($m), 2009 97
Figure 51: Immuno Chemistry Market, India, Category Contribution (%), 2009 98
Figure 52: Immuno Chemistry, India, Revenue ($m) by Segment, Historic, 2002-2009 99
Figure 53: Immuno Chemistry, India, Revenue ($m) by Segment, Forecast, 2009-2016 101
Figure 54: Disease Specific Immunochemistry, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 103
Figure 55: Disease Specific Immunochemistry, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 105
Figure 56: Drug Related Testing, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 107
Figure 57: Drug Related Testing, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Figure 58: Endocrinology Tests, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Figure 59: Endocrinology Tests, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 111
Figure 60: Immunochemistry Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113
Figure 61: Immunochemistry Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 114
Figure 62: Immuno Chemistry, India, Company Share (%), 2009 117
Figure 63: Infectious Immunology, Market Segmentation 119
Figure 64: Infectious Immunology Market, India, Revenue Mix ($m), 2009 120
Figure 65: Infectious Immunology Market, India, Category Contribution (%), 2009 121
Figure 66: Infectious Immunology, India, Revenue ($m) by Segment, Historic, 2002-2009 122
Figure 67: Infectious Immunology, India, Revenue ($m) by Segment, Forecast, 2009-2016 124
Figure 68: Infectious Immunology, India, Company Share (%), 2009 127
Figure 69: Microbiology Culture, Market Segmentation 129
Figure 70: Microbiology Culture Market, India, Revenue Mix ($m), 2009 130
Figure 71: Microbiology Culture Market, India, Category Contribution (%), 2009 131
Figure 72: Microbiology Culture, India, Revenue ($m) by Segment, Historic, 2002-2009 132
Figure 73: Microbiology Culture, India, Revenue ($m) by Segment, Forecast, 2009-2016 134
Figure 74: Microbiology Analyzers, India, Revenue ($m) by Sub-Segment, Historic, 2002-2009 136
Figure 75: Microbiology Analyzers, India, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 138
Figure 76: Microbiology Culture, India, Company Share (%), 2009 141
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),India In Vitro Diagnostics Market, 2009 143
Figure 78: Beckman Coulter, Inc., Company Share (%),India In Vitro Diagnostics Market, 2009 144
Figure 79: Transasia Bio-Medicals Ltd., Company Share (%),India In Vitro Diagnostics Market, 2009 145
Figure 80: Siemens Healthcare, Company Share (%),India In Vitro Diagnostics Market, 2009 146
Figure 81: Abbott Laboratories, Company Share (%),India In Vitro Diagnostics Market, 2009 147
Figure 82: Sysmex Corporation, Company Share (%),India In Vitro Diagnostics Market, 2009 148
Figure 83: GlobalData Methodology 189